Physiologically Based Models of the Lung S. Moll H. Meyer S. Mielordt Seminar Pharmakokinetik - Mathematische Modelle und ihre Anwendung - WS 03/04 FU.

Slides:



Advertisements
Similar presentations
Dosimetry in Risk Assessment and a bit More Mel Andersen McKim Conference QSAR and Aquatic Toxicology & Risk Assessment June 27-29, 2006.
Advertisements

Improving Candidate Quality Through the Prediction of Clinical Outcome.
CHEMICAL CARCINOGENS CHEMICAL CARCINOGENS. What is a Chemical Carcinogen?  Any chemical compound which has been shown to cause cancer in humans or in.
Human Body Drug Simulation Nathan Liles Benjamin Munda.
Harvard Center for Risk Analysis A Comprehensive Evaluation of the Potential Health Risks Associated with Occupational and Environmental Exposure to Styrene.
1 Some Deterministic Models in Mathematical Biology: Physiologically Based Pharmacokinetic Models for Toxic Chemicals Cammey E. Cole Meredith College March.
Exposure Assessment Thanks to Marc Rigas, PhD for an earlier version of this lecture Much of the materials is drawn from Paustenbach, DJ. (2000) The practice.
Developing Secondary Organic Aerosol (SOA) Code for the MCM David Johnson (Mike Jenkin and Steve Utembe) Department of Environmental Science and Technology,
Pharmacotherapy in the Elderly Paola S. Timiras May, 2007.
Pharmacotherapy in the Elderly Judy Wong
Metabolism of Xenobiotics I. General Overview Aug 25, 2011 L.M. Ball Rosenau 158 ENVR/TOXC 442 Fall 2011.
Factors Affecting Distribution and Metabolism. Chemical Factors Lipophilicity Structure Ionization Chirality.
Risk Assessment II Dec 9, Is there a “safe” dose ? For effects other than cancer:
Pharmacokinetics Chapter 4.
Guidance for Industry M4S: The CTD-Safety
ILSI Risk Science Institute Acrylamide Toxicity: Research to Address Key Data Gaps Presented by Dr. Stephen S. Olin ILSI Risk Science Institute.
Supercourse Environmental Exposure Assessment And Biomarkers Wael Al-Delaimy, MD, PhD.
Pharmacokinetics (PK): What the body does to the drug? Most drugs: Enter the body by crossing barriers Distributed by the blood to the site of action Biotransform.
Approaches for Evaluating the Relevance of Multiroute Exposures in Establishing Guideline Values for Drinking Water Contaminants Kannan Krishnan, Université.
© 2004 by Thomson Delmar Learning, a part of the Thomson Corporation. Fundamentals of Pharmacology for Veterinary Technicians Chapter 4 Pharmacokinetics.
Methylene Chloride a case study for Dose-Dependent Transitions Raymond M. David, Ph.D. Eastman Kodak Company © Eastman Kodak Company, 2005.
Animal Studies and Human Health Consequences Sorell L. Schwartz, Ph.D. Department of Pharmacology Georgetown University Medical Center.
Environmental Biology for Engineers and Scientists D.A. Vaccari, P.F. Strom, and J.E. Alleman © John Wiley & Sons, 2005 Chapter 17 – The Science of Poisons.
Bioavailability Dr Mohammad Issa.
Biomarkers Biomarkers - markers in biological systems with a sufficently long half-life which allow location where in the biological system change occur.
1 Pharmacology Pharmacokinetics –Absorption –Distribution –Biotransformation (metabolism) –Excretion Pharmacodynamics –Receptor binding –Signal transduction.
Chapter 4 Pharmacokinetics Copyright © 2011 Delmar, Cengage Learning.
FUNDAMENTALS OF OCCUPATIONAL TOXICOLOGY Vesa Riihimäki, MD, PhD, MSc Finnish Institute of Occupational Health.
PHARMACOKINETICS Part 3.
Drug Administration Pharmacokinetic Phase (Time course of ADME processes) Absorption Distribution Pharmaceutical Phase Disintegration of the Dosage Form.
The Hamner Institutes for Health Sciences | SOT Meeting March 9, 2011 Update on Formaldehyde Case Study: Adaptation of the Biologically Based Dose Response.
!!!……Molecular Target Concept A gonist Antagonist.
1 Some Deterministic Models in Mathematical Biology: Physiologically Based Pharmacokinetic Models for Toxic Chemicals Cammey E. Cole Meredith College January.
1 Pharmacokinetics: Introduction Dr Mohammad Issa.
Drug Metabolism and Prodrugs
FACTORS INFLUENCING THE DOSE FOR GASES, VAPORS Yves Alarie, Ph.D Professor Emeritus U niversity of Pittsburgh,USA.
NUATRC/TCEQ Air Toxics Workshop October Air Toxics Air Toxics: What We Know, What we Don’t Know, and What We Need to Know Human Health Effects –
European Patients’ Academy on Therapeutic Innovation The key principles of pharmacology.
Drug Transfer into Milk: Clinical Methods & Issues Patrick J. McNamara University of Kentucky College of Pharmacy College of Pharmacy.
TOXICOLOGY The study of chemical or physical agents and their interaction with biologic systems to produce a response in a organism. The dose makes the.
Toxic effects Acute / chronic Reversible / irreversible Immediate / delayed Idiosyncratic - hypersensitivity Local / systemic Target organs.
PHT 415 BASIC PHARMACOKINETICS
Metabolomics Sarah C. Rutan Ernst Bezemer Department of Chemistry Virginia Commonwealth University July 29 – 31, 2003.
Pharmacology I BMS 242 Lecture 4 Pharmacokienetic Principles (3&4): Drug Metabolism and Excretion [Elimination] Dr. Aya M. Serry 2016.
1 Biopharmaceutics Dr Mohammad Issa Saleh. 2 Biopharmaceutics Biopharmaceutics is the science that examines this interrelationship of the physicochemical.
ADME Dr Basma Damiri Toxicology In general, a toxicant should be absorbed in order to have an effect. True or false? Why? False Some toxicants.
11 Simulating of in vivo metabolism taking into account detoxification logics.
Predicting Blood Lead Reduction Outcomes Craig J. Boreiko, Ph.D. International Lead Zinc Research Organization Prague 2013.
What are hazards in food system? Physical – Fish bones, nail, hair, etc… Chemical – Environmental pollutants Heavy metal Polymers – Pesticides – Antibiotic.
Pharmacology I Session One Pharmacological Principles.
Physiology for Engineers
Transportation and Transformation of Xenobiotics
Chapter 5 Drug Metabolism
Pharmacokinetics and Pharmacodynamics
Life Span Consideration
Biologic Monitoring A. H. Mehrparvar, MD
Drug Metabolism Drugs are most often eliminated by biotransformation and/or excretion into the urine or bile. The process of metabolism transforms lipophilic.
Kinetics, Modeling Oct 19, 2009 Casarett and Doull,
Biopharmaceutics Dr Mohammad Issa Saleh.
Biomedical Research.
Dosimetry and Kinetics
Kinetics, Modeling Oct 15, 2006 Casarett and Doull,
Food Chemicals Toxicity
Microfluidic Cell Culture Analog Devices to Mimic Animal Exposures to Toxins and Drugs Our group has developed microfluidic in vitro devices that mimic.
Pharmacokinetics: Metabolism of Drugs
Conceptual Subdivisions of Pharmacology
Conceptual Subdivisions of Pharmacology
PREDICT.
Basic Biopharmaceutics
Pharmacokinetics/Pharmacodynamics
Presentation transcript:

Physiologically Based Models of the Lung S. Moll H. Meyer S. Mielordt Seminar Pharmakokinetik - Mathematische Modelle und ihre Anwendung - WS 03/04 FU Berlin

2 Outline Pharmacokinetics vs. Toxicokinetics Physiology matters: The Lung Development of a Physiologically Based Toxicokinetic Model Concrete example: Styrene and its metabolites Simulation Discussion

3 Toxicokinetics The study of the absorption, distribution and elimination of toxic compounds in the living organism Analogous to Pharmacokinetics, but undesired uptake of chemicals by Lung Skin Gastrointestinal tract

4 Toxicokinetics II The lung is the main source for the absorption of toxic compounds Industrial chemicals Exhaust gas Military toxins Insecticides

5 Lung - Evolution Developed from intestinal protuberance Evolved to maximize surface (  alveoles) and throughput Limiting factor for peak power of a creature

6 The Lung

7 Lung – further

8 Pre - PBPK - Modeling

9 PBPK - Modeling

10 Modeling Goals Transferability of results from animals to human Fewer details sometimes better Causalities by Anatomy Biochemistry, metabolism Disease dependent changes

11 Lung – Models Which facts are important to include? What can be left out? Degrees of Freedom (e.g.: physiological accuracy, # compartments, wash-in wash-out, metabolism, tissue layers between blood and air,...) Possible one, two, three compartments (e.g.: upper respiratory tract, bronchia, alveoles)

12 One Model for Everyone? One model sufficient? - Gender - Age - Genetic variation Toxicokinetics vs.Toxicodynamics  Intention is crucial for modeling! Isopropanol metabolite in blood

13 Styrene Unsaturated aromatic hydrocarbon Very lipophil Noxious to microorganisms Ubiquitous in Environment Sweet smell Used in plastic industry as a preproduct

14 Styrene and its Metabolic Degradation Styrene (ST) Cytochrome P-450 Styrene Oxide (SO) Phenylethylene Glycol Epoxide Hydrolase Further metabolism and excretion + glutathione (GSH) x-Phenyl- 2-hydroxy- ethylmercapturic acid Only lung und liver...

15 Styrene 7,8 oxide DNA strand breaks occur after SO exposure SO-DNA adducts have been found in mice and in cultured mammalian cells SO causes leukemia and lymphoma in humans Lung and stomach cancer in animals

16 The Lung - Model by Csanády et. al. Gy.A. Csana´dy et al.

17 Styrene Level Comparison ST – Concentration mg/l

18 Styrene Levels in different Tissues ST – Concentration mg/l

19 SO – Calculation in Lung Tissue ParameterMouseRatHumanUnits Vmax8.9e-49.3e-42.5e-6mmol/h/l Km1.8e-21.4e-11.8e-2mmol/l Vmax/Km Michaelis-Menten properties of CYP 450 – ST interaction SO = ([ST] * Vmax …) / ([ST] + Km …) e-4

20 SO – Level (Lung isolated) Linear Logarithmic S O – Concentration mg/l

21 S O – Concentration mg/l Hypothetical SO (Lung isolated) Linear, with hypothetical safety factor Logarithmic, with hypothetical safety factor S O – Concentration mg/l

22 Degradation of Styrene oxide Gy.A. Csana´dy et al.  GSH depletion supported model assumption

23 SO - Long-term Burden S O – Concentration mg/l

24 Conclusion Use species specific differential PBPK instead of estimated safety factors Metabolizing lung is important for risk evaluation of air toxics Description of biological mechanisms... - is foundation of model construction - allows transfer of results from animal experiments to human

25 Discussion What kind of facts can be shown by the modeling? Transfer of animal data to human possible? Model complexity vs. precision Parameter estimation verification Fitting of Data - Cross Validation

26 References  A toxicokinetic model for styrene and its metabolite styrene-7,8- oxide in mouse, rat and human with special emphasis on the lung (Gy.A. Csanády, W. Kessler, H.D. Hoffmann, J.G. Filser)  Evaluation of the Potential Impact of Age and Gender-Specific Lung Morphology and Ventilation Rate on the Dosimeter of Vapors (Ramesh Sarangapani et.al.)  PKQuest: A general physiologically based pharmacokinetic model. Introduction and application to propranolol (David G. Levitt)  PBPK-Toolkit (Wolfram Liebermeister)   

27 Sundowner ntpaul.sprog.auc.dk